Abeona Therapeutics (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced key pipeline updates during the Company’s 2018 R&D Day. As quoted in the press release: “The important clinical and preclinical updates we shared today further establish Abeona’s pathway to bring long-term value … Continued
The post Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs appeared first on Investing News Network.
Original Article: Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs